📷 Image: Wikimedia Commons / the Illustrated London News, 1876*
National
Unichem’s Goa Facility Receives Five USFDA Observations
✍️ Medical Dialogues
🗓 28 Sep 2026, 10:33 AM
👁 21
Unichem Laboratories' manufacturing plant in Goa has been issued five observations by the US Food and Drug Administration. The observations were communicated following a recent inspection.
The US Food and Drug Administration issued five observations to Unichem Laboratories' Goa-based facility after an inspection. The observations pertain to regulatory compliance standards that the agency evaluates during such visits.
Unichem's Goa plant is an important site for the company's production activities, serving both domestic and international markets. The facility manufactures a range of pharmaceutical products under strict quality guidelines.
FDA observations are a routine part of the inspection process, and the company is expected to review the findings and submit a timely response. Addressing these points helps maintain adherence to global manufacturing standards.
Unichem's Goa plant is an important site for the company's production activities, serving both domestic and international markets. The facility manufactures a range of pharmaceutical products under strict quality guidelines.
FDA observations are a routine part of the inspection process, and the company is expected to review the findings and submit a timely response. Addressing these points helps maintain adherence to global manufacturing standards.